Genome Editing Market Analysis Report & Size 2028
[Research Report] The genome editing market size was valued at US$ 5,199.40 million in 2021 and is projected to reach US$ 16,986.69 million by 2028; it is estimated to register a CAGR of 18.4% from 2021 to 2028.
Analyst’s Viewpoint
Genome editing technique is utilized for the changes that are to be done in the DNA of a cell or an organism. The technique involves cutting DNA sequences for the addition or removing the DNA in the genome. The changes in the genome are done for the required characteristics of the cell. Genome editing is done for the research purpose, the treatment of the diseases, and the biotechnological purpose. The global genome editing market growth is attributable to the rise in prevalence of cancer & other genetic disorders and continuous technological advancements in gene-editing tools are factors driving the market growth. Furthermore, technological advancements in healthcare IT allow the use of artificial intelligence (AI) for manufacturing CRISPR Systems which are expected to foster genome editing and enhance the genome editing market growth in the coming years. For instance, In March 2019, Oxford Biomedica plc collaborated with Microsoft Research for R&D of cloud and machine learning to improve the production and quality of next-generation gene therapy vectors such as LentiVector. Under this collaboration, Oxford Biomedica has utilized Microsoft’s Azure intelligent cloud platform to develop in silico models and innovative algorithms to advance the next-generation cell and gene delivery technology.
Market Overview
Genome editing or gene editing is a type of genetic editing that involves inserting, removing, or replacing DNA in an organism's genome to treat a particular disease with an engineered nuclease or molecular scissors. The nucleases create site-specific double-stranded breaks in the genome where they are repaired by either nonhomologous end joining or homologous recombination, resulting in a targeted mutation. Some of the factors driving the genome editing market growth include an increase in cancer and other genetic disorders, a growing preference for personalized medicine, a rise in private and public funding, and rapid advances in sequencing and genome editing technologies. Another factor contributing to the genome editing market growth is collaboration. Eli Lilly, for example, partnered with Precision BioSciences in November 2020 to develop in vivo treatments for genetic disorders using the ARCUS platform, a collaborative effort that could generate USD 2.7 billion for the Durham, NC, company, which develops genome editing and CAR T immunotherapies. Thus, collaborations would increase genome editing market growth during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Genome Editing Market: Strategic Insights
Market Size Value in US$ 5,199.40 million in 2021 Market Size Value by US$ 16,986.69 million by 2028 Growth rate CAGR of 18.4% from 2021 to 2028 Forecast Period 2021-2028 Base Year 2021
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Genome Editing Market: Strategic Insights
| Market Size Value in | US$ 5,199.40 million in 2021 |
| Market Size Value by | US$ 16,986.69 million by 2028 |
| Growth rate | CAGR of 18.4% from 2021 to 2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Driver
Rise in Prevalence of Cancer and Other Genetic Disorders
According to the World Health Organization (WHO), cancer is the biggest cause of death worldwide, with approximately 10 million deaths in 2020. Overall, the global burden of cancer incidence and death is quickly increasing, reflecting both population aging and growth, as well as changes in the prevalence and distribution of the key cancer risk factors, many of which are related to socio-economic development. CANCER TODAY enabled a comprehensive assessment of the cancer burden worldwide in 2020, based on the GLOBOCAN estimates of incidence, mortality, and prevalence for 2020 in 185 countries or territories for 36 cancer types by sex and age group. According to the recent estimates, the incidence of cancer has been increasing at an alarming rate, making hepatocellular carcinoma (HCC the fifth most common cancer in men and the seventh most common cancer in women. HCC is likely to contribute to ~5.6% of all human cancers, thereby increasing the burden in 2020. The HCC is known to be the second leading cause of cancer-related deaths worldwide. Almost 85% of HCCs occur in developing countries. Other types of liver cancers are cholangiocellular carcinoma (CCC), a malignant disease of the liver bile ducts, and hepatoblastoma. Hepatoblastoma is the most common malignant tumor of the liver in children. According to the Centers for Disease Control and Prevention (CDC), ~21,000 men and ~8,000 women develop liver cancer each year in the US, and about 16,000 men and 8,000 women die from the disease. Thus, a rise in the global prevalence of liver diseases, including chronic and acute diseases and microbial infections, increases the demand for liver models.
A chromosomal abnormality can be detected in about one out of every 150 live births. Yet even this high incidence represents only a small fraction of chromosome mutations since the vast majority are lethal and result in prenatal death or stillbirth. Indeed, 50% of all first-trimester miscarriages and 20% of all second-trimester miscarriages are estimated to involve a chromosomally abnormal fetus. Although Down syndrome is the most well-known and well-recognized autosomal trisomies, it is only diagnosed in around one out of every 800 live births. Many cancer biology investigations are now using CRISPR as a standard approach. The CRISPR/Cas9 system has been shown to be effective in treating metastatic tumors, which is a big step toward discovering a cancer cure. The CRISPR-LNPs system contains a messenger RNA that encodes for the Cas9 CRISPR enzyme, which operates as molecular scissors to cut the DNA of cells. CRISPR-based studies have opened new doors to treating hereditary or developmental neurological disorders (HNDs) such as fragile X syndrome and Down syndrome.
Thus, the increasing factors of genome editing are expected to boost the genome editing market growth during the forecast period.
Segmental Analysis
Technology Insights
Based on technology, the genome editing market is segmented into CRISPR, TALEN, antisense, and other. The CRISPR segment is likely to hold the largest share of the market in 2021 and is anticipated to register the highest CAGR in the market during the forecast period, due to their incumbent usage, high volume consumption, and product innovation. The clustered regularly interspaced short palindromic repeats (CRISPR) are associated with the Cas genes that essential for adaptive immunity in selected bacteria and archaea. The CRISPR enables the organisms to respond the changes and elimination of invading genetic material. There are types of the CRISPR mechanisms have been adopted for genome-editing protocols. The first one is wild-type Cas9, second is mutated Cas9 and the third is nuclease-deficient Cas9.
The CRISPR-Cas9 is faster, cheaper, and more accurate than the other technologies of DNA editing and is used for the wide applications. It is the simplest, most versatile, and precise method of genetic manipulation. The companies which offer the CRISPR are Sangamo Therapeutics, Editas Medicine, ThermoFisher Scientific, Horizon Discovery Groups among the others. Owing to the simple, fast, and accurate property of the CRISPR the market for the segment is expected to grow at the fastest rate in the coming forecast years.
Application Insights
The global genome editing market, based on application, is segmented into cell line engineering, genetic engineering, diagnostic applications, drug discovery, and others. In 2021, the cell line engineering segment was likely to hold the largest share of the market. Moreover, the segment is also expected to witness growth in its demand at the fastest CAGR from 2021 to 2028, owing to the rise in the detection and diagnosis of various medical conditions across the globe. Cell line engineering is majorly done in laboratories, and it is performed to understand the basic biology behind the diseases and therapeutics. Cell line engineering provides benefits such as optimizing cell lines for the recombinant protein expression and characterization of the protein profile of genetically modified organisms. Cell line engineering enables the production of various industrial and commercial products that gain much more revenue as the products are produced per the desired requirement.
The market players such as Horizon Discovery, ThermoFisher Scientific, Lonza, Merck KGaA, Biognosys, and more provide the products and services for cell line engineering. There are various advantages, such as being cost-effective, easy to use, providing an unlimited supply of material, and bypassing ethical concerns associated with the use of animal and human tissues. In addition, cell line engineering has benefitted researchers for developing a vaccine, testing drug metabolism and cytotoxicity, antibody production, the study of gene function, generation of artificial tissues (and synthesis of biological compounds. Thus, the advantages of cell line engineering are likely to grow significantly in the coming forecast years which is expected to drive the genome editing market growth.
End User Insights
The global genome editing market, based on end user, is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and clinical research organizations (CRO's). In 2021, the Pharmaceutical and Biotechnology Companies segment is likely to hold the largest share of the market. Moreover, the segment is also expected to witness growth in its demand at a fastest CAGR during 2021 to 2028, owing to the rise in the detection and diagnosis of various medical conditions across the globe.
Regional Analysis
Global Genome editing market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The North American region is the largest shareholder in the global genome editing market. The genome editing market growth is widely seen in countries such as the US and Canada, which is driven by the factors including increasing development for gene-based therapies, growing collaborations among companies and government bodies, increasing funding by the government agencies to promote technologies to develop CRISPR products and increasing demand for genome editing. Whereas Mexico is expected to offer growth opportunities for the genome editing market due to the increasing adoption of genome editing to treat genetic disorders and cancer. Also, the growing clinical trials for genome editing are expected to push genome editing market.
In North America, the US is the largest genome editing market. Livestock groups provide consumers with different products and services, including meat, milk, eggs, and others. The genetic variation within livestock helps in produces the good quality raw material for evolving through natural selection in answer to changing conditions and human-managed genetic improvement plans.
Moreover, the increasing prevalence of genetic disorders and adoption of advanced gene therapy for treatment of chronic diseases is expected to drive the market in the country in the forecast period. For instance, as per the data published by the NIH’s National Library of Medicine IN July 2021, Cystic fibrosis is among the common genetic disease observed in the white population in the US. The incidence rate for the disease is 1 in 2,500 to 3,500 white newborns. However, Cystic fibrosis is relatively lower among the other ethnic groups in the country. The disease incidence among these groups is about 1 in 17,000 African Americans and 1 in 31,000 Asian Americans. Furthermore, the factors such as the rising adoption of gene therapy for the treatment of cancer, associated products are being introduced by the market players, support of the regulatory agencies, and others are expected to support the genome editing-related market in the US. For instance, In May 2021, US Food and Drug Administration (FDA) approved Lumakras (Sotorasib) for a targeted therapy for non-small cell lung cancer patients with tumors that express the G12C mutation in the KRAS gene.
Thermo Fisher Scientific Inc.; Merck KGaA; Lonza; Horizon Discovery Group plc.; Integrated DNA Technologies; GenScript; New England Biolabs; Eurofins Scientific; CRISPR Therapeutics and Editas Medicine are among the leading players operating in the global genome editing market growth. Several other essential market players were analyzed for a holistic view of the market and its ecosystem. The report provides detailed market insights, which help the key players strategize their genome editing market growth. A few developments are mentioned below:
Genome Editing Market Report Scope
- In November 2021, Integrated DNA Technologies (IDT), a leading comprehensive genomics solutions provider, has launched its rhAmpSeq CRISPR Analysis System, which offers an end-to-end solution for characterizing and quantifying the full array of on- and off-target genome editing events in CRISPR research projects.
- In December 2021, Editas Medicine, Inc., a leading genome editing company, announced that the U.S. Food and Drug Administration (FDA) has cleared the IND for EDIT-301 for the treatment of transfusion-dependent beta thalassemia (TDT), enabling the Company to initiate a Phase 1/2 clinical study of EDIT-301 in TDT patients.
- In August 2020, Horizon Discovery Group plc a global leader in the application of gene editing and gene modulation for cell line engineering, today announced the addition of single-cell RNA seq-linked pooled CRISPR screening to its CRISPR screening services portfolio. The platform offers high-quality screening data and biological insight to address critical gaps in target identification and validation.
- In December 2021, Eurofins Scientific has agreed to acquire Japan-based testing services provider Genetic Lab (G Lab) from Transgenic for an undisclosed sum. G Lab is involved in delivering molecular biology based testing for diagnostics, biomarker development and drug discovery.
- In May 2021, New England Biolabs, inc., a leading supplier of life science reagents, announced that it entered into an agreement to acquire Fluorogenics Limited (FGL), a lyophilization R&D service company based in the UK. Under the terms of the agreement, FGL will become a wholly-owned subsidiary of NEB.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Technology, Application, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The global genome editing market based on technology, is segmented into CRISPR, TALEN, Antisense, and others. The CRISPR segment held the largest share of the market in 2021 and register the highest CAGR during the forecast period.
Genome editing technologies enable scientists to change DNA, leading to changes in physical traits, like eye color and disease risk. Scientists use different technologies to do this. These technologies act like scissors, cutting the DNA at a specific spot. Then scientists can remove, add, or replace the DNA where it was cut. CRISPR is simpler, faster, cheaper, and more accurate than older genome editing methods. Many scientists who perform genome editing now use CRISPR.
The genome editing market majorly consists of the players such as Thermo Fisher Scientific Inc.; Merck KGaA; Lonza; Horizon Discovery Group plc.; Integrated DNA Technologies; GenScript; New England Biolabs; Eurofins Scientific; CRISPR Therapeutics; Editas Medicine amongst others.
The factors that are driving and restraining factors that will affect the genome editing market in the coming years. Factors such as the rising prevalence of cancer, the growing rate of genetic disorders. However, the high cost of genomics hampers the genome editing market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Genome Editing Market– By Technology
1.3.2 Genome Editing Market– By Application
1.3.3 Genome Editing Market– By End User
1.3.4 Genome Editing Market– By Geography
2. Genome Editing Market– Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Genome Editing Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East and Africa PEST Analysis
4.2.5 South and Central America PEST Analysis
4.3 Expert Opinion
5. Genome EditingMarket – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in Prevalence of Cancer and Other Genetic Disorders
5.1.2 Continuous Technological Advancements in Gene-Editing Tools
5.2 Market Restraints
5.2.1 High Cost of Genomic Equipment
5.3 Market Opportunities
5.3.1 Developing Biotechnology Industry in Emerging Regions
5.4 Future Trends
5.4.1 Technological Innovations
5.5 Impact Analysis
6. Genome Editing Market– Global Analysis
6.1 Global Genome Editing Market Revenue Forecast and Analysis
6.2 Global Genome Editing Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Global Genome Editing Market Revenue and Forecasts To 2028– by Technology
7.1 Overview
7.2 Global Genome Editing Market, By Technology, 2021 & 2028 (%)
7.3 Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
7.3.1 Overview
7.3.2 CRISPR: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
7.4 TALEN
7.4.1 Overview
7.4.2 TALEN: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
7.5 Antisense
7.5.1 Overview
7.5.2 Antisense: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
8. Genome Editing Market Revenue and Forecasts To 2028 – Application
8.1 Overview
8.2 Global Genome Editing Market Share, By Application - 2021 & 2028 (%)
8.3 Cell Line Engineering
8.3.1 Overview
8.3.2 Cell Line Engineering: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
8.4 Genetic Engineering
8.4.1 Overview
8.4.2 Genetic Engineering: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
8.5 Diagnostic Applications
8.5.1 Overview
8.5.2 Diagnostic Applications: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
8.6 Drug Discovery
8.6.1 Overview
8.6.2 Drug Discovery: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
9. Genome Editing Market Revenue and Forecasts To 2028 – End User
9.1 Overview
9.2 Global Genome Editing Market Share by End User - 2021 & 2028 (%)
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Overview
9.3.2 Pharmaceutical and Biotechnology Companies: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
9.4 Clinical Research Organizations (CRO’s)
9.4.1 Overview
9.4.2 Clinical Research Organizations: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10. Genome Editing Market Revenue and Forecasts to 2028 – Geographical Analysis
10.1 North America: Genome Editing Market
10.1.1 Overview
10.1.2 North America: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3 North America: Genome Editing Market, by Technology, 2019–2028 (US$ Million)
10.1.4 North America: Genome Editing Market, by Applications, 2019–2028 (US$ Million)
10.1.5 North America: Genome Editing Market, End User, 2019–2028 (US$ Million)
10.1.6 North America: Genome Editing Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.1 Overview
10.1.6.1.2 US: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.3 US: Genome Editing Market, by Technology, 2019–2028 (US$ Million)
10.1.6.1.4 US: Genome Editing Market, by Applications, 2019–2028 (US$ Million)
10.1.6.1.5 US: Genome Editing Market, End User, 2019–2028 (US$ Million)
10.1.6.2 Canada: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.1 Overview
10.1.6.2.2 Canada: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.3 Canada: Genome Editing Market, by Technology, 2019–2028 (US$ Million)
10.1.6.2.4 Canada: Genome Editing Market, by Applications, 2019–2028 (US$ Million)
10.1.6.2.5 Canada: Genome Editing Market, End User, 2019–2028 (US$ Million)
10.1.6.3 Mexico: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.1 Overview
10.1.6.3.2 Mexico: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.3 Mexico: Genome Editing Market, by Technology, 2019–2028 (US$ Million)
10.1.6.3.4 Mexico: Genome Editing Market, by Applications, 2019–2028 (US$ Million)
10.1.6.3.5 Mexico: Genome Editing Market, End User, 2019–2028 (US$ Million)
10.2 Europe: Genome Editing Market
10.2.1 Overview
10.2.2 Europe: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.3 Europe: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.2.4 Europe: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
10.2.4.1 Europe: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.5 Europe: Genome Editing Market, by Country, 2021 & 2028 (%)
10.2.5.1 Germany: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.5.1.1 Overview
10.2.5.1.2 Germany: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.5.1.3 Germany: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.2.5.1.4 Germany: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
10.2.5.1.5 Germany: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.5.2 France: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.5.2.1 Overview
10.2.5.2.2 France: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.5.2.3 France: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.2.5.2.4 France: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
10.2.5.2.5 France: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.5.3 UK: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.5.3.1 Overview
10.2.5.3.2 UK: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.5.3.3 UK: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.2.5.3.4 UK: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
10.2.5.3.5 UK: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.5.4 Italy: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.5.4.1 Overview
10.2.5.4.2 Italy: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.5.4.3 Italy: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.2.5.4.4 Italy: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
10.2.5.4.5 Italy: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.5.5 Spain: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.5.5.1 Overview
10.2.5.5.2 Spain: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.5.5.3 Spain: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.2.5.5.4 Spain: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
10.2.5.5.5 Spain: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.5.6 Rest of Europe: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.5.6.1 Overview
10.2.5.6.2 Rest of Europe: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
10.2.5.6.3 Rest of Europe: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.2.5.6.4 Rest of Europe: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
10.2.5.6.5 Rest of Europe: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.3 Asia Pacific: Genome Editing Market Revenue and Forecast to 2028
10.3.1 Overview
10.3.2 Asia Pacific: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)
10.3.3 Asia Pacific: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
10.3.4 Asia Pacific: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)
10.3.5 Asia Pacific: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)
10.3.6 Asia Pacific: Genome Editing Market, by Country, 2021 & 2028 (%)
10.3.6.1 China: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.1 Overview
10.3.6.1.2 China: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.3 China: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.4 China: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.5 China: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)
10.3.6.2 Japan: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.1 Overview
10.3.6.2.2 Japan: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.3 Japan: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.4 Japan: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.5 Japan: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)
10.3.6.3 India: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.1 Overview
10.3.6.3.2 India: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.3 India: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.4 India: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.5 India: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)
10.3.6.4 South Korea: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.1 Overview
10.3.6.4.2 South Korea: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.3 South Korea: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.4 South Korea: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.5 South Korea: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)
10.3.6.5 Australia: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.1 Overview
10.3.6.5.2 Australia: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.3 Australia: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.4 Australia: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.5 Australia: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)
10.3.6.6 Rest of Asia Pacific: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.1 Overview
10.3.6.6.2 Rest of Asia Pacific: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.3 Rest of Asia Pacific: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.4 Rest of Asia Pacific: Genome Editing Market, by Application, Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.5 Rest of Asia Pacific: Genome Editing Market, by End User, Revenue and Forecast to 2028 (US$ Million)
10.4 Middle East & Africa Genome Editing Market Revenue and Forecasts To 2028
10.4.1 Overview
10.4.2 Middle East & Africa Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10.4.3 Middle East & Africa: Genome Editing Market Revenue and Forecast to 2028, Technology (US$ Million)
10.4.4 Middle East & Africa: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
10.4.4.1 Middle East & Africa: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.4.5 Middle East & Africa: Genome Editing Market, by Country, 2021 & 2028 (%)
10.4.5.1 UAE: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10.4.5.1.1 Overview
10.4.5.1.2 UAE: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10.4.5.1.3 UAE: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
10.4.5.1.4 UAE: Genome Editing Market, by Applications, Revenue and Forecast To 2028 (US$ Million)
10.4.5.1.5 UAE: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.4.5.2 Saudi Arabia: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10.4.5.2.1 Overview
10.4.5.2.2 Saudi Arabia: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10.4.5.2.3 Saudi Arabia: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
10.4.5.2.4 Saudi Arabia: Genome Editing Market, by Applications, Revenue and Forecast To 2028 (US$ Million)
10.4.5.2.5 Saudi Arabia: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.4.5.3 South Africa: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10.4.5.3.1 Overview
10.4.5.3.2 South Africa: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10.4.5.3.3 South Africa: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
10.4.5.3.4 South Africa: Genome Editing Market, by Applications, Revenue and Forecast To 2028 (US$ Million)
10.4.5.3.5 South Africa: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.4.5.4 Rest of Middle East and Africa: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10.4.5.4.1 Overview
10.4.5.4.2 Rest of Middle East and Africa: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10.4.5.4.3 Rest of Middle East & Africa: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
10.4.5.4.4 Rest of Middle East & Africa: Genome Editing Market, by Applications, Revenue and Forecast To 2028 (US$ Million)
10.4.5.4.5 Rest of Middle East and Africa: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.5 South and Central America: Genome Editing Market Revenue and Forecast To 2028
10.5.1 Overview
10.5.2 South and Central America: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10.5.3 South and Central America: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
10.5.4 South and Central America: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
10.5.5 South and Central America: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.5.6 South and Central America: Genome Editing Market, by Country, 2021 & 2028 (%)
10.5.6.1 Argentina: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.1 Overview
10.5.6.1.2 Argentina: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.3 Argentina: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.4 Argentina: Genome Editing Market, by Applications, Revenue and Forecast To 2028 (US$ Million)
10.5.6.1.5 Argentina: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.5.6.2 Brazil: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.1 Overview
10.5.6.2.2 Brazil: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.3 Brazil: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.4 Brazil: Genome Editing Market, by Applications, Revenue and Forecast To 2028 (US$ Million)
10.5.6.2.5 Brazil: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.5.6.3 Rest of South and Central America: Genome Editing Market– Revenue and Forecast to 2028 (USD Mn)
10.5.6.3.1 Overview
10.5.6.3.2 Rest of South and Central America: Genome Editing Market– Revenue and Forecast to 2028 (USD Mn)
10.5.6.3.3 Rest of South & Central America: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.4 Rest of South & Central America: Genome Editing Market, by Applications, Revenue and Forecast To 2028 (US$ Million)
10.5.6.3.5 Rest of South and Central America: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11. Impact Of COVID-19 Pandemic on Genome Editing Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Genome Editing Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 MERCK KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Lonza
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Horizon Discovery Group plc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Integrated DNA Technologies
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 GenScript
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 New England Biolabs
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Eurofins Scientific
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 CRISPR Therapeutics
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Editas Medicine
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 Glossary of Terms
LIST OF TABLES
Table 1. North America Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Genome Editing Market, End User– Revenue and Forecast to 2028 (US$ Million)
Table 4. US Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 5. US Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 6. US Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 10. Mexico: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 11. Mexico Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13. Europe: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 14. Europe: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 15. Europe: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 16. Germany: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 17. Germany: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 18. Germany: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 19. France: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 20. France: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 21. France: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 22. UK: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 23. UK: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 24. UK: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 25. Italy: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 26. Italy: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 27. Italy: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 28. Spain: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 29. Spain: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 30. Spain: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 31. Rest of Europe: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 32. Rest of Europe: Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)
Table 33. Rest of Europe: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 34. Asia Pacific: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 35. Asia Pacific: Genome Editing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 36. Asia Pacific: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 37. China: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 38. China: Genome Editing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 39. China: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 40. Japan: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 41. Japan: Genome Editing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 42. Japan: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 43. India: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 44. India: Genome Editing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 45. India: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 46. South Korea: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 47. South Korea: Genome Editing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 48. South Korea: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 49. Australia: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 50. Australia: Genome Editing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 51. Australia: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 52. Rest of Asia Pacific: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 53. Rest of Asia Pacific: Genome Editing Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 54. Rest of Asia Pacific: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 55. Middle East & Africa: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
Table 56. Middle East & Africa: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
Table 57. Middle East & Africa: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 58. UAE: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
Table 59. UAE: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
Table 60. UAE: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 61. Saudi Arabia: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
Table 62. Saudi Arabia: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
Table 63. Saudi Arabia: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 64. South Africa: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
Table 65. South Africa: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
Table 66. South Africa: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 67. Rest of Middle East & Africa: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
Table 68. Rest of Middle East & Africa: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
Table 69. Rest of Middle East and Africa: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 70. South and Central America: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
Table 71. South and Central America: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
Table 72. South and Central America: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 73. Argentina: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
Table 74. Argentina: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
Table 75. Argentina: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 76. Brazil: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
Table 77. Brazil: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
Table 78. Brazil: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 79. Rest of South & Central America: Genome Editing Market, by Technology, Revenue and Forecast to 2028 (US$ Million)
Table 80. Rest of South & Central America: Genome Editing Market, by Applications, Revenue and Forecast to 2028 (US$ Million)
Table 81. Rest of South and Central America: Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 82. Organic Developments Done by Companies
Table 83. Inorganic Developments Done by Companies
Table 84. Glossary of Terms, Genome Editing Market
LIST OF FIGURES
Figure 1. Genome Editing Market Segmentation
Figure 2. Cell Therapy Bioprocessing Segmentation, By Region
Figure 3. Global Genome Editing Market Overview
Figure 4. CRISPR Held Largest Share of Technology Segment in Genome Editing Market
Figure 5. Asia Pacific to Show Remarkable Growth During Forecast Period
Figure 6. Genome Editing Market, by Geography (US$ Million)
Figure 7. Global Genome Editing Market– Leading Country Markets (US$ Million)
Figure 8. Global Genome Editing Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East and Africa: PEST Analysis
Figure 13. South and Central America: PEST Analysis
Figure 14. Expert Opinion
Figure 15. Genome Editing Market Impact Analysis of Drivers and Restraints
Figure 16. Global Genome Editing Market– Revenue Forecast and Analysis – 2020-2028
Figure 17. Global Genome Editing Market– By Geography Forecast and Analysis – 2020-2028
Figure 18. Market Positioning of Key Players in Global Genome Editing Market
Figure 19. Global Genome Editing Market, by Technology, 2021 & 2028 (%)
Figure 20. CRISPR: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 21. TALEN: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 22. Antisense: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 23. Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 24. Global Genome Editing Market Share, by Application - 2021 & 2028 (%)
Figure 25. Cell Line Engineering: Genome Editing Market Revenue and Forecasts To 2028 (US$ Million)
Figure 26. Genetic Engineering: Genome Editing Market Revenue and Forecasts To 2028 (US$ Million)
Figure 27. Diagnostic Applications: Genome Editing Market Revenue and Forecasts To 2028 (US$ Million)
Figure 28. Drug Discovery: Genome Editing Market Revenue and Forecasts To 2028 (US$ Million)
Figure 29. Others: Genome Editing Market Revenue and Forecasts To 2028 (US$ Million)
Figure 30. Global Genome Editing Market Share by End User - 2021 & 2028 (%)
Figure 31. Pharmaceutical and Biotechnology Companies: Genome Editing Market Revenue and Forecasts To 2028 (US$ Million)
Figure 32. Clinical Research Organizations: Genome Editing Market Revenue and Forecasts To 2028 (US$ Million)
Figure 33. Academic and Research Institutes: Genome Editing Market Revenue and Forecasts To 2028 (US$ Million)
Figure 34. North America: Genome Editing Market, by Key Country – Revenue (2021) (US$ Million)
Figure 35. North America Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 36. North America: Genome Editing Market, by Country, 2021 & 2028 (%)
Figure 37. US: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Canada: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. Mexico: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. Europe: Genome Editing Market, by Key Country – Revenue (2021) (US$ Million)
Figure 41. Europe: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 42. Europe: Genome Editing Market, by Country, 2021 & 2028 (%)
Figure 43. Germany: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. France: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. UK: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. Italy: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 47. Spain: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 48. Rest of Europe: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 49. Asia Pacific: Genome Editing Market, by Key Country – Revenue (2021) (US$ Million)
Figure 50. Asia Pacific: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 51. Asia Pacific: Genome Editing Market, by Country, 2021 & 2028 (%)
Figure 52. China: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 53. Japan: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 54. India: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 55. South Korea: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 56. Australia: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 57. Rest of Asia Pacific: Genome Editing Market– Revenue and Forecast to 2028 (US$ Million)
Figure 58. Middle East & Africa Genome Editing Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 59. Middle East & Africa Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 60. Middle East & Africa: Genome Editing Market, by Country, 2021 & 2028 (%)
Figure 61. UAE: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 62. Saudi Arabia: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 63. South Africa: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 64. Rest of Middle East and Africa: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 65. South and Central America: Genome Editing Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 66. South and Central America: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 67. South and Central America: Genome Editing Market, by Country, 2021 & 2028 (%)
Figure 68. Argentina: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 69. Brazil: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)
Figure 70. Rest of South and Central America: Genome Editing Market– Revenue and Forecast to 2028 (USD Mn)
Figure 71. Impact of COVID-19 Pandemic in North American Country Markets
Figure 72. Impact of COVID-19 Pandemic in European Country Markets
Figure 73. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 74. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 75. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets
Figure 76. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Genome Editing Market
- THERMO FISHER SCIENTIFIC INC.
- MERCK KGaA
- Lonza
- Horizon Discovery Group plc.
- Integrated DNA Technologies
- GenScript
- New England Biolabs
- Eurofins Scientific
- CRISPR Therapeutics
- Editas Medicine
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For